Q Therapeutics
Blood & Organ Banks · Utah, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
417 S Wakara Way Ste 3510, Salt Lake Cit...Phone Number
(801) 582-5400Website
www.qthera.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
2
1
2
About Q Therapeutics
Q Therapeutics is a biopharmaceutical company focused on developing innovative cellular therapies for central nervous system (CNS) diseases. Their flagship product, Q-Cells, utilizes human glial progenitor cells to repair neuronal function at sites of CNS injury, specifically targeting conditions such as Transverse Myelitis. The company aims to revolutionize treatment for neurodegenerative diseases by providing allogeneic, off-the-shelf therapies that are non-genetically manipulated. Q Therapeutics is positioned to address the needs of patients suffering from debilitating CNS disorders with their unique cell-based therapy approach.Explore more
Q Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Q Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Q Therapeutics launches new products
Check if Q Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Q Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Q Therapeutics has new funding data
Check out if Q Therapeutics is spiking on competitors!
Click to see if Q Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Q Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Q Therapeutics
Recommended Actions
Reach out to Masked Content who joined Q Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Q Therapeutics
Compare insights from companies similar to Q Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Q Therapeutics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Q Therapeutics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Q Therapeutics.
Q Therapeutics financials insights
Gather financial insights about Q Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$52K
Q Therapeutics Tech Stack
A closer look at the technologies used by Q Therapeutics
Q Therapeutics News & Media
Q Therapeutics Receives Orphan Drug Designation for Transverse Myelitis
FDA DESIGNATION WOULD PROVIDE 7 YEARS OF MARKET EXCLUSIVITY UPON MARKET APPROVAL OF Q-CELLS®
Read more news
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding Q Therapeutics
Sign Up For FreeTo access detailed company insights
Q Therapeutics is a biopharmaceutical company focused on developing innovative cellular therapies for central nervous system (CNS) diseases. Their flagship product, Q-Cells, utilizes human glial progenitor cells to repair neuronal function at sites of CNS injury, specifically targeting conditions such as Transverse Myelitis. The company aims to rev... Read More
